|
Volumn 48, Issue 1, 2008, Pages 56-59
|
Relationship between cardiac 123I-metaiodobenzylguanidine scintigraphy and cardiovascular autonomic function test (standing test) in Parkinson's disease
a,b a a,c a a a,d e b |
Author keywords
Autonomic nerve; MIBG myocardial scintigraphy; Noradrenaline; Parkinson's disease; Standing test
|
Indexed keywords
3 IODOBENYZLGUANIDINE IODINE 123;
CONTRAST MEDIUM;
UNCLASSIFIED DRUG;
(3 IODOBENZYL)GUANIDINE;
BIOLOGICAL MARKER;
DIAGNOSTIC AGENT;
NORADRENALIN;
RADIOACTIVE IODINE;
RADIOPHARMACEUTICAL AGENT;
ADRENALIN BLOOD LEVEL;
ARTICLE;
BLOOD PRESSURE;
CARDIOVASCULAR FUNCTION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FUNCTION TEST;
HEART RATE;
HEART SCINTISCANNING;
HUMAN;
NERVE CONDUCTION;
PARKINSON DISEASE;
SYMPATHETIC NERVE;
ADRENERGIC SYSTEM;
AGED;
BLOOD;
BODY POSTURE;
FEMALE;
HEART;
INNERVATION;
MALE;
MIDDLE AGED;
NEUROLOGIC EXAMINATION;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
SCINTISCANNING;
3-IODOBENZYLGUANIDINE;
AGED;
BIOLOGICAL MARKERS;
DIAGNOSTIC TECHNIQUES, NEUROLOGICAL;
FEMALE;
HEART;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGED;
NOREPINEPHRINE;
PARKINSON DISEASE;
POSTURE;
RADIOPHARMACEUTICALS;
SYMPATHETIC NERVOUS SYSTEM;
|
EID: 38749152500
PISSN: 0009918X
EISSN: None
Source Type: Journal
DOI: 10.5692/clinicalneurol.48.56 Document Type: Article |
Times cited : (1)
|
References (10)
|